Search Results - Claude Sportès

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O Trial

    Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced... by Amber B. Clemmons, Julianne Orr, Benjamin Andrick, Arpita Gandhi, Claude Sportès, David L. DeRemer

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory Cells

    IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory Cells by Steven A. Rosenberg, Claude Sportès, Mojgan Ahmadzadeh, Terry J. Fry, Lien T. Ngo, Susan Schwarz, Maryalice Stetler‐Stevenson, Kathleen E. Morton, Sharon Mavroukakis, Michel Morre, Renaud Buffet, Crystal L. Mackall, Ronald E. Gress

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation

    Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation by Michael Bishop, Robert M. Dean, Seth M. Steinberg, Jeanne Odom, Steven Z. Pavletic, C. Chow, Stefania Pittaluga, Claude Sportès, Nancy M. Hardy, Juan Gea‐Banacloche, Arne Kolstad, Ronald E. Gress, Daniel H. Fowler

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy

    Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy by Claude Sportès, Rebecca R. Babb, Michael Krumlauf, Frances T. Hakim, Seth M. Steinberg, Catherine K. Chow, Margaret R. Brown, Thomas A. Fleisher, Pierre Noël, Irina Marić, Maryalice Stetler‐Stevenson, J Engel, Renaud Buffet, Michel Morre, Robert J. Amato, Andrew L. Pecora, Crystal L. Mackall, Ronald E. Gress

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

    Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets by Claude Sportès, Frances T. Hakim, Sarfraz Memon, Hua Zhang, Kevin S. Chua, Margaret R. Brown, Thomas A. Fleisher, Michael Krumlauf, Rebecca R. Babb, Catherine K. Chow, Terry J. Fry, Julie Engels, Renaud Buffet, Michel Morre, Robert J. Amato, David Venzon, Robert Korngold, Andrew L. Pecora, Ronald E. Gress, Crystal L. Mackall

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

    Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States by Jeffrey I. Cohen, Elaine S. Jaffe, Janet K. Dale, Stefania Pittaluga, Helen E. Heslop, Cliona M. Rooney, Stephen Gottschalk, Catherine M. Bollard, V. Koneti Rao, Adriana Marques, Peter D. Burbelo, Siu-Ping Turk, Rachael Fulton, Alan S. Wayne, Richard F. Little, Mitchell S. Cairo, Nader Kim El‐Mallawany, Daniel H. Fowler, Claude Sportès, Michael Bishop, Wyndham H. Wilson, Stephen E. Straus

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation

    Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation by James N. Kochenderfer, Mark E. Dudley, Robert O. Carpenter, Sadik H. Kassim, Jeremy J. Rose, William G. Telford, Frances T. Hakim, David Halverson, Daniel H. Fowler, Nancy M. Hardy, Anthony R. Mato, Dennis D. Hickstein, Juan Gea‐Banacloche, Steven Z. Pavletic, Claude Sportès, Irina Marić, Steven A. Feldman, Brenna Hansen, Jennifer Wilder, Bazetta Blacklock-Schuver, Bipulendu Jena, Michael Bishop, Ronald E. Gress, Steven A. Rosenberg

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    National Institutes of Health Chronic Graft-versus-Host Disease Staging in Severely Affected Patients: Organ and Global Scoring Correlate with Established Indicators of Disease Severity and Prognosis

    National Institutes of Health Chronic Graft-versus-Host Disease Staging in Severely Affected Patients: Organ and Global Scoring Correlate with Established Indicators of Disease Sev... by Kristin Baird, Seth M. Steinberg, Lana Grković, Dražen Pulanić, Edward W. Cowen, Sandra A. Mitchell, Kirsten M. Williams, Manuel B. Datiles, Rachel Bishop, Carol W. Bassim, Jacqueline W. Mays, Dean Edwards, Kristen Cole, Daniele Avila, Tiffany Taylor, Amanda Urban, Galen O. Joe, Leora E. Comis, Ann Berger, Pamela Stratton, Dan Zhang, James H. Shelhamer, Juan Gea‐Banacloche, Claude Sportès, Daniel H. Fowler, Ronald E. Gress, Steven Z. Pavletic

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: